0001209191-23-030202.txt : 20230517
0001209191-23-030202.hdr.sgml : 20230517
20230517163148
ACCESSION NUMBER: 0001209191-23-030202
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230515
FILED AS OF DATE: 20230517
DATE AS OF CHANGE: 20230517
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lemaitre Dan
CENTRAL INDEX KEY: 0001478479
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35621
FILM NUMBER: 23932220
MAIL ADDRESS:
STREET 1: 2 MUSICK
CITY: IRVINE
STATE: CA
ZIP: 92618
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GLOBUS MEDICAL INC
CENTRAL INDEX KEY: 0001237831
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 043744954
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2560 GENERAL ARMISTEAD AVENUE
CITY: AUDUBON
STATE: PA
ZIP: 19403
BUSINESS PHONE: 610-930-1800
MAIL ADDRESS:
STREET 1: 2560 GENERAL ARMISTEAD AVENUE
CITY: AUDUBON
STATE: PA
ZIP: 19403
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-05-15
0
0001237831
GLOBUS MEDICAL INC
GMED
0001478479
Lemaitre Dan
VALLEY FORGE BUSINESS CENTER
2560 GENERAL ARMISTEAD AVENUE
AUDUBON
PA
19403
1
0
0
0
0
Class A Common Stock
2023-05-15
4
M
0
1450
23.95
A
12250
D
Class A Common Stock
2023-05-15
4
M
0
10500
24.10
A
22750
D
Class A Common Stock
2023-05-15
4
M
0
14000
25.52
A
36750
D
Class A Common Stock
2023-05-15
4
M
0
17500
26.27
A
54250
D
Class A Common Stock
2023-05-15
4
S
0
43450
56.9845
D
10800
D
Stock Option (Right to Buy Class A Common Stock)
23.95
2023-05-15
4
M
0
1450
0.00
D
2024-01-23
Class A Common Stock
1450
0
D
Stock Option (Right to Buy Class A Common Stock)
24.10
2023-05-15
4
M
0
10500
0.00
D
2025-01-20
Class A Common Stock
10500
0
D
Stock Option (Right to Buy Class A Common Stock)
25.52
2023-05-15
4
M
0
14000
0.00
D
2026-01-25
Class A Common Stock
14000
0
D
Stock Option (Right to Buy Class A Common Stock)
26.27
2023-05-15
4
M
0
17500
0.00
D
2027-01-30
Class A Common Stock
17500
0
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.77 to $57.215, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
These options were granted on January 23, 2014 and are fully vested.
These options were granted on January 20, 2015 and are fully vested.
These options were granted on January 25, 2016 and are fully vested.
These options were granted on January 30, 2017 and are fully vested.
/s/ Kelly G. Huller, Attorney-in-Fact
2023-05-17